Literature DB >> 21104863

Voluntary exercise induces structural remodeling in the hearts of dystrophin-deficient mice.

Jeffrey M Costas1, David J Nye, Jessica B Henley, Jeffrey H Plochocki.   

Abstract

In this exploratory study, we test the hypothesis that voluntary exercise affects the progression of dystrophic changes in the left ventricle of the heart. Wild-type (C57BL/10ScSn) and dystrophin-deficient (mdx) mice, aged 7 weeks, were divided into sedentary and exercise-treated groups and tested for differences in cardiac histomorphometry. Exercised mdx mice were found to exhibit significantly enlarged ventricles and thinner lateral ventricular walls than sedentary mdx mice (P < 0.05). Trichrome staining indicated the presence of fibrotic lesions in the left ventricular myocardium in 20% of the exercised mdx group. Fibrotic lesions were not found in control or sedentary mdx mice. No histomorphometric differences were found between treatment groups in wild-type mice. Our findings suggest voluntary exercise may accelerate the progression of ventricular dilation and fibrosis in young mdx mice. The effects of exercise on cardiac remodeling should be considered during the treatment of cardiac disease in dystrophin-deficient patients.

Entities:  

Mesh:

Year:  2010        PMID: 21104863     DOI: 10.1002/mus.21783

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  13 in total

1.  Long-term wheel running compromises diaphragm function but improves cardiac and plantarflexor function in the mdx mouse.

Authors:  Joshua T Selsby; Pedro Acosta; Meg M Sleeper; Elisabeth R Barton; H Lee Sweeney
Journal:  J Appl Physiol (1985)       Date:  2013-07-03

2.  Diaphragm degeneration and cardiac structure in mdx mouse: potential clinical implications for Duchenne muscular dystrophy.

Authors:  Isabel Cristina Chagas Barbin; Juliano Alves Pereira; Matheus Bersan Rovere; Drielen de Oliveira Moreira; Maria Julia Marques; Humberto Santo Neto
Journal:  J Anat       Date:  2016-01-29       Impact factor: 2.610

3.  The effects of glucocorticoid and voluntary exercise treatment on the development of thoracolumbar kyphosis in dystrophin-deficient mice.

Authors:  Daniel Brereton; Jeffrey Plochocki; Daniel An; Jeffrey Costas; Erin Simons
Journal:  PLoS Curr       Date:  2012-10-10

4.  Gene Therapy Rescues Cardiac Dysfunction in Duchenne Muscular Dystrophy Mice by Elevating Cardiomyocyte Deoxy-Adenosine Triphosphate.

Authors:  Stephen C Kolwicz; John K Hall; Farid Moussavi-Harami; Xiolan Chen; Stephen D Hauschka; Jeffrey S Chamberlain; Michael Regnier; Guy L Odom
Journal:  JACC Basic Transl Sci       Date:  2019-10-02

5.  Implications for Cardiac Function Following Rescue of the Dystrophic Diaphragm in a Mouse Model of Duchenne Muscular Dystrophy.

Authors:  Corinne A Betts; Amer F Saleh; Carolyn A Carr; Sofia Muses; Kim E Wells; Suzan M Hammond; Caroline Godfrey; Graham McClorey; Caroline Woffindale; Kieran Clarke; Dominic J Wells; Michael J Gait; Matthew J A Wood
Journal:  Sci Rep       Date:  2015-06-26       Impact factor: 4.379

6.  Antioxidant Properties of Whole Body Periodic Acceleration (pGz).

Authors:  Arkady Uryash; Jorge Bassuk; Paul Kurlansky; Francisco Altamirano; Jose R Lopez; Jose A Adams
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

7.  Prevention of exercised induced cardiomyopathy following Pip-PMO treatment in dystrophic mdx mice.

Authors:  Corinne A Betts; Amer F Saleh; Carolyn A Carr; Suzan M Hammond; Anna M L Coenen-Stass; Caroline Godfrey; Graham McClorey; Miguel A Varela; Thomas C Roberts; Kieran Clarke; Michael J Gait; Matthew J A Wood
Journal:  Sci Rep       Date:  2015-03-11       Impact factor: 4.379

8.  Second-generation compound for the modulation of utrophin in the therapy of DMD.

Authors:  Simon Guiraud; Sarah E Squire; Benjamin Edwards; Huijia Chen; David T Burns; Nandini Shah; Arran Babbs; Stephen G Davies; Graham M Wynne; Angela J Russell; David Elsey; Francis X Wilson; Jon M Tinsley; Kay E Davies
Journal:  Hum Mol Genet       Date:  2015-05-01       Impact factor: 6.150

9.  AAV9-mediated gene transfer of desmin ameliorates cardiomyopathy in desmin-deficient mice.

Authors:  M B Heckmann; R Bauer; A Jungmann; L Winter; K Rapti; K-H Strucksberg; C S Clemen; Z Li; R Schröder; H A Katus; O J Müller
Journal:  Gene Ther       Date:  2016-04-21       Impact factor: 5.250

10.  Pip6-PMO, A New Generation of Peptide-oligonucleotide Conjugates With Improved Cardiac Exon Skipping Activity for DMD Treatment.

Authors:  Corinne Betts; Amer F Saleh; Andrey A Arzumanov; Suzan M Hammond; Caroline Godfrey; Thibault Coursindel; Michael J Gait; Matthew Ja Wood
Journal:  Mol Ther Nucleic Acids       Date:  2012-08-14       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.